EV/EBITDA
9.63
-0.32-3.22%
8 min ago
Summary
- As of March 12, 2025, SUPN EV/EBITDA is 9.63, with a fall of -0.32 (-3.22%) during the most recent trading day.
- Over the past year, SUPN EV/EBITDA has dropped by -10.01 (-50.97%).
- SUPN EV/EBITDA is now -88.69% below its all-time high of 85.14.
Performance
SUPN EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
SUPN EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | -3.2% | -3.2% | -3.2% |
| 1 m1 month | -21.1% | -21.1% | -20.9% |
| 3 m3 months | -25.1% | -14.3% | -13.2% |
| 6 m6 months | -30.3% | +1.5% | +1.6% |
| ytdytd | -13.3% | -13.3% | -13.2% |
| 1 y1 year | -51.0% | -2.9% | -4.7% |
| 5 y5 years | +64.0% | +65.4% | +96.0% |
SUPN EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -21.8% | 9.55 | +0.8% | |
| 3 m | 3-month | 13.23 | -27.2% | 9.55 | +0.8% |
| 6 m | 6-month | 14.36 | -32.9% | 9.55 | +0.8% |
| 1 y | 1-year | 23.48 | -59.0% | 9.55 | +0.8% |
| 3 y | 3-year | 23.48 | -59.0% | 9.53 | +1.1% |
| 5 y | 5-year | 23.48 | -59.0% | 5.41 | +78.0% |
| alltime | all time | 85.14 | -88.7% | -144.43 | +106.7% |
Supernus Pharmaceuticals EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | 9.63(-13.3%) |
| 2024 | 11.11(-35.4%) |
| 2023 | 17.21(+15.4%) |
| 2022 | 14.91(+8.4%) |
| 2021 | 13.75(+99.3%) |
| 2020 | 6.90(-15.4%) |
| 2019 | 8.16(-28.0%) |
| Date | Value |
|---|---|
| 2018 | 11.34(-35.7%) |
| 2017 | 17.63(-15.0%) |
| 2016 | 20.73(-33.4%) |
| 2015 | 31.14(-133.7%) |
| 2014 | -92.53(+2456.1%) |
| 2013 | -3.62(-25.1%) |
| 2012 | -4.83 |
FAQ
- What is Supernus Pharmaceuticals EV/EBITDA?
- What is the all time high EV/EBITDA for Supernus Pharmaceuticals?
- What is SUPN EV/EBITDA year-to-date change?
- What is Supernus Pharmaceuticals EV/EBITDA year-on-year change?
What is Supernus Pharmaceuticals EV/EBITDA?
The current EV/EBITDA of SUPN is 9.63
What is the all time high EV/EBITDA for Supernus Pharmaceuticals?
Supernus Pharmaceuticals all-time high EV/EBITDA is 85.14
What is SUPN EV/EBITDA year-to-date change?
Supernus Pharmaceuticals EV/EBITDA has changed by -1.48 (-13.32%) since the beginning of the year
What is Supernus Pharmaceuticals EV/EBITDA year-on-year change?
Over the past year, SUPN EV/EBITDA has changed by -10.01 (-50.97%)